Floatz logo

Eloxatin

Elderly (People Aged 65 or More)

Junpeng WangPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the Elderly (People Aged 65 or More) cohort.

Asset / SponsorPhaseRating
Ferric Carboxymaltose [Ferinject]
Fundación para la Investigación del Hospital Clínico de Valencia
Phase 4BB
Raltitrexed
Junpeng Wang
Phase 2CCC
Idarubicine
Junpeng Wang
Phase 2CCC
Inno-206
Junpeng Wang
Phase 2CCC

Same molecule, other indications

Eloxatin is also rated in:

exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
colon adenocarcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
colorectal neoplasmDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →